Bruker Expanding Into Lila's Territory

The real threat is not another startup, it is a large lab vendor turning autonomous science into an add on sale for customers it already owns. Lila built a tightly integrated stack of models, robotics, and execution infrastructure, but Bruker now offers an open self driving lab that bundles robotics, analytics, lab software, and AI orchestration on a vendor agnostic backbone, which maps closely to the same budget, workflow, and buyer conversation.1 2 3 4

• Bruker has an installed base advantage. Chemspeed became part of Bruker in 2024, and by February 2026 Bruker was positioning Chemspeed plus SciY as a production ready self driving lab for R&D, QC, and even GMP environments. That means the pitch starts inside accounts that already trust Bruker for regulated lab infrastructure.2 3 4
• The product shape is converging from the bottom up. HighRes has long sold orchestration software that connects instruments, protocols, and sites. Its 2026 Opentrons partnership pushes that layer closer to an AI control plane, where a scientist can start from natural language intent and let software route work across robots and schedulers without picking one proprietary science stack.5 6 7
• Lila is still more vertically integrated than either incumbent path. It owns hypothesis generation, experiment design, and physical execution as one system. But incumbents do not need to match that full vision to win share. They only need to supply the orchestration and compliance friendly infrastructure layer that enterprise labs are willing to buy first.1 2 5

This market is moving toward a split where incumbents own the trusted execution layer and newer companies try to own the scientific brain. The winners will be the companies that can connect AI planning to real instruments, real lab data, and real enterprise workflows without forcing customers to rip out the systems they already run.1 2 5 7